Vetigenics, co-founded by Nicola Mason, BVetMed, PhD, Professor of Medicine & Pathobiology at Penn Vet, Don Siegel, MD, PhD, Professor, Pathology & Laboratory Medicine at Penn Medicine, and Adriann Sax, MBA, President, CEO and Co-Founder, recently secured $6 million in seed financing. The company, which was formed in partnership with PCI Ventures is a clinical-stage animal health biotechnology company that specializes in developing antibody-based therapeutics for pets. The funding will be used to further advance clinical-stage programs toward pivotal trials, accelerate preclinical candidates, and scale the company’s operations and manufacturing. Read more here.